Europe Enzymatic DNA Synthesis Market Forecast to 2028 -Regional Analysis - by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), Technol

Europe Enzymatic DNA Synthesis Market Forecast to 2028-Regional Analysis- by Product Type (Custom DNA Synthesis and DNA Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, and Others), Technology (SOLA, CRISPR, PCR, and Others), and End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, and Others)

The Europe enzymatic DNA synthesis market is expected to grow from US$ 78.55 million in 2022 to US$ 727.79 million by 2028. It is estimated to record a CAGR of 44.9% from 2022 to 2028.

Surging Number of Product Launches Fuels Europe Enzymatic DNA Synthesis Market Growth

Advancements in medical technologies and an increase in investments in R&D by manufacturers have resulted in the launch of various modern systems for genetic and molecular biology studies. Companies in the Europe enzymatic DNA synthesis market are involved in different product development activities. In November 2021, OriCiro Genomics Inc. launched the OriCiro Cell-Free Switching system. In June 2021, DNA Script commercially launched its SYNTAX platform with the first product—the SYNTAX System. This system is the first benchtop nucleic acid printer powered by enzymatic DNA synthesis (EDS) technology. The SYNTAX System is a fully integrated, automated printer that synthesizes 96 DNA oligos in parallel, each of length of up to 60 nucleotides, and delivers them ready for use in molecular biology and genomics workflows, eliminating the need for additional handling. In January 2021, Codex DNA, Inc. signed a strategic collaboration and licensing agreement with Pfizer to access and further develop the novel EDS technology of Codex DNA for its potential application in Pfizer’s mRNA-based vaccines and other biopharma products.

Such developments help end users meet the rising demand for technically advanced systems that can efficiently manage data and provide accurate results, thereby boosting the Europe enzymatic DNA synthesis market growth.

Europe Enzymatic DNA Synthesis Market Overview

The Europe enzymatic DNA synthesis market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the enzymatic DNA synthesis market. The market is expected to witness significant growth during the forecast period due to factors such as the growing prevalence of genetic diseases and the favorable initiatives to detect diseases in the region.

Exhibit: Europe Enzymatic DNA Synthesis Market Revenue and Forecast to 2028 (US$ Million)

Europe Enzymatic DNA Synthesis Market Segmentation

The Europe enzymatic DNA synthesis market is segmented into product type, application, technology, end user, and country.

Based on product type, the Europe enzymatic DNA synthesis market is segmented into custom DNA synthesis and DNA library synthesis. The DNA library synthesis segment held a larger share of the Europe enzymatic DNA synthesis market in 2022.

Based on application, the Europe enzymatic DNA synthesis market is segmented into synthetic biology, genetic engineering, therapeutic antibodies, vaccine design, and others. The synthetic biology segment held the largest share of the Europe enzymatic DNA synthesis market in 2022.

Based on technology, the Europe enzymatic DNA synthesis market is segmented into SOLA, CRISPR, PCR, and others. The PCR segment held the largest share of the Europe enzymatic DNA synthesis market in 2022.

Based on end user, the Europe enzymatic DNA synthesis market is segmented into academic & research institutes, biotech & pharmaceutical companies, diagnostic laboratories, and others. The biotech and pharmaceutical companies segment held the largest share of the Europe enzymatic DNA synthesis market in 2022

Based on country, the Europe enzymatic DNA synthesis market is segmented int o Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Germany dominated the share of the Europe enzymatic DNA synthesis market in 2022.

Camena Bio; DNA Script; Evonetix; GenScript Biotech Corporation; Synbio Technologies; Telesis Bio Inc; Touchlight; and Twist Bioscience are the leading companies operating in the Europe enzymatic DNA synthesis market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe enzymatic DNA synthesis market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe enzymatic DNA synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution